Home › Funds › Aquamarine Financial (Cayman) Ltd › DRTS
Aquamarine Financial (Cayman) Ltd position in DRTS
ALPHA TAU MEDICAL LTD · Health Care
Aquamarine Financial (Cayman) Ltd reported holding 721,501 shares of DRTS (ALPHA TAU MEDICAL LTD) in its Q3 2026 13F filing — a position valued at US$10.8M, representing 0.55% of its reported portfolio and ranking #11 among its reported holdings. Aquamarine Financial (Cayman) Ltd has disclosed DRTS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Aquamarine Financial (Cayman) Ltd's DRTS position evolved
Aquamarine Financial (Cayman) Ltd first disclosed a stake in DRTS in Q1 2026 at 721,501 shares (US$5.1M). The position peaked in Q3 2026 at 721,501 shares, worth US$10.8M. Across 3 filings, Aquamarine Financial (Cayman) Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 721,501 shares valued at US$10.8M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 721.50K | $5.10M | New |
| Q2 2026 | 721.50K | $9.08M | Hold |
| Q3 2026 | 721.50K | $10.76M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DRTS and 13F data
DRTS (ALPHA TAU MEDICAL LTD) is a Health Care company. 69 other funds we track also report a position in DRTS — the largest reported positions include Gem Investment Advisors, LLC (US$21.4M), Pier Capital, LLC (US$10.9M), Daytona Street Capital LLC (US$1.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DRTS
- Gem Investment Advisors, LLC 1.43M sh · $21.39M · Q3 2026
- Pier Capital, LLC 730.21K sh · $10.89M · Q3 2026
- Daytona Street Capital LLC 120.84K sh · $1.80M · Q3 2026
- Dauntless Investment Group, LLC 61.20K sh · $769.90K · Q2 2026
- WISCONSIN CAPITAL MANAGEMENT LLC 47.00K sh · $700.77K · Q3 2026
- SATOVSKY ASSET MANAGEMENT LLC 36.64K sh · $460.88K · Q2 2026
More on Aquamarine Financial (Cayman) Ltd
FAQ
How long has Aquamarine Financial (Cayman) Ltd held DRTS?
Aquamarine Financial (Cayman) Ltd has disclosed DRTS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Aquamarine Financial (Cayman) Ltd's current position in DRTS?
As of Q3 2026, Aquamarine Financial (Cayman) Ltd holds 721.50K shares of DRTS (ALPHA TAU MEDICAL LTD), valued at $10.76M, representing 0.55% of its reported portfolio and ranking #11.
Has Aquamarine Financial (Cayman) Ltd been buying or selling DRTS?
In the latest 13F filing (Q3 2026), Aquamarine Financial (Cayman) Ltd held unchanged its position in DRTS. The position peaked in Q3 2026 at 721.50K shares.
Which other funds hold DRTS?
Other major institutional holders of DRTS include Gem Investment Advisors, LLC, Pier Capital, LLC, Daytona Street Capital LLC, among 69 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.